ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,000,071 | -24.9% | 223,300 | -0.3% | 0.01% | 0.0% |
| Q2 2023 | $7,987,840 | +44.7% | 224,000 | +3.1% | 0.01% | +25.0% |
| Q1 2023 | $5,519,420 | -44.0% | 217,300 | -10.5% | 0.00% | -42.9% |
| Q4 2022 | $9,847,968 | +25.1% | 242,800 | +1.9% | 0.01% | +16.7% |
| Q3 2022 | $7,873,000 | -5.3% | 238,200 | +0.9% | 0.01% | 0.0% |
| Q2 2022 | $8,313,000 | -23.0% | 236,100 | +0.6% | 0.01% | 0.0% |
| Q1 2022 | $10,798,000 | -25.3% | 234,800 | +7.7% | 0.01% | -33.3% |
| Q4 2021 | $14,453,000 | +6.0% | 218,000 | -0.2% | 0.01% | 0.0% |
| Q3 2021 | $13,641,000 | -24.2% | 218,500 | +0.6% | 0.01% | -18.2% |
| Q2 2021 | $17,997,000 | +21.7% | 217,300 | -2.6% | 0.01% | +10.0% |
| Q1 2021 | $14,787,000 | -12.3% | 223,000 | +1.5% | 0.01% | -16.7% |
| Q4 2020 | $16,858,000 | +78.7% | 219,700 | +0.3% | 0.01% | +71.4% |
| Q3 2020 | $9,434,000 | +1.4% | 219,100 | +1.7% | 0.01% | -12.5% |
| Q2 2020 | $9,307,000 | +93.6% | 215,500 | +29.0% | 0.01% | +60.0% |
| Q1 2020 | $4,807,000 | -53.8% | 167,100 | +1.8% | 0.01% | -54.5% |
| Q4 2019 | $10,415,000 | +130.1% | 164,200 | +2.2% | 0.01% | +120.0% |
| Q3 2019 | $4,526,000 | +8.2% | 160,600 | +1.8% | 0.01% | 0.0% |
| Q2 2019 | $4,182,000 | +57.8% | 157,800 | +9.3% | 0.01% | +66.7% |
| Q1 2019 | $2,650,000 | +52.3% | 144,400 | +3.1% | 0.00% | +50.0% |
| Q4 2018 | $1,740,000 | -33.3% | 140,100 | +3.0% | 0.00% | -33.3% |
| Q3 2018 | $2,607,000 | +40.9% | 136,000 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $1,850,000 | +994.7% | 136,000 | +48.8% | 0.00% | – |
| Q1 2017 | $169,000 | +19.0% | 91,400 | 0.0% | 0.00% | – |
| Q4 2016 | $142,000 | -78.9% | 91,400 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $672,000 | +38.3% | 91,400 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $486,000 | – | 91,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |